LEADER 00594oas 2200193z- 450 001 9910219641903321 035 $a(CKB)3360000000351859 035 $a(EXLCZ)993360000000351859 100 $a20180708cuuuuuuuu -u- - 101 0 $afre 200 00$aAccident Law: An Excessive Standard May Be Efficient 210 $cifo Institute for Economic Research 517 $aAccident Law 606 $aLaw$xGeneral and Others 615 4$aLaw$xGeneral and Others 906 $aJOURNAL 912 $a9910219641903321 996 $aAccident Law: An Excessive Standard May Be Efficient$92052105 997 $aUNINA LEADER 00991nam a22002531i 4500 001 991002974479707536 005 20030821191942.0 008 030925s1961 fi |||||||||||||||||eng 035 $ab12362943-39ule_inst 035 $aARCHE-041047$9ExL 040 $aBiblioteca Interfacoltà$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a170 100 1 $aKajanto, Iiro$0171184 245 10$aOvid's conception of fate /$cby Iiro Kajanto 260 $aTurku :$bTurun yliopisto,$c1961 300 $a38 p. ;$c26 cm 440 0$aTurun yliopiston julkaisuja = Annales universitatis turkuensis.$nSeries B ;$v80 650 4$aOvidio Nasone, Publio$xConcetto di fato 907 $a.b12362943$b02-04-14$c08-10-03 912 $a991002974479707536 945 $aLE002 D Ann. 379/080$g1$i2002000147523$lle002$o-$pE0.00$q-$rl$so $t0$u0$v0$w0$x0$y.i1276758x$z08-10-03 996 $aOvid's conception of fate$9170991 997 $aUNISALENTO 998 $ale002$b08-10-03$cm$da $e-$feng$gfi $h0$i1 LEADER 04088nam 2200661 a 450 001 9910957300903321 005 20251017110151.0 010 $a9786610183364 010 $a9780309169158 010 $a0309169151 010 $a9781280183362 010 $a1280183365 010 $a9780309500791 010 $a0309500796 035 $a(CKB)111069351128634 035 $a(EBL)3375351 035 $a(SSID)ssj0000229506 035 $a(PQKBManifestationID)11947170 035 $a(PQKBTitleCode)TC0000229506 035 $a(PQKBWorkID)10172347 035 $a(PQKB)10441817 035 $a(MiAaPQ)EBC3375351 035 $a(Perlego)4731803 035 $a(DNLM)1165517 035 $a(BIP)7955939 035 $a(EXLCZ)99111069351128634 100 $a20030224d2002 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aProtecting our forces $eimproving vaccine acquisition and availability in the U.S. military /$fStanley M. Lemon ... [et al.], editors ; Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military, Medical Follow-up Agency, Institute of Medicine 205 $a1st ed. 210 $aWashington, D.C. ;$a[Great Britain] $cNational Academy Press$dc2002 215 $a1 online resource (xxi, 133 pages) $ccolor illustrations 300 $aDescription based upon print version of record. 311 1 $a9780309084994 311 1 $a0309084997 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Preface""; ""Acknowledgments""; ""Reviewers""; ""Contents""; ""Boxes, Figures, and Tables""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction and History""; ""2 Resources, Responsibilities, and Dynamics in the Military's Vaccine Mission""; ""3 Current Status of Vaccines for Military Personnel""; ""4 Recommendations with Accompanying Analysis of Limitations Imposed by Current Department of Defense Structure for Managing Acquisition of Vaccines Against Infectious Diseases""; ""References"" 327 $a""Appendix A Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability""""Appendix B Open Meeting Agendas""; ""Appendix C Committee and Staff Biographies"" 330 $aInfectious diseases continue to pose a substantial threat to the operational capacity of military forces. Protecting Our Forces reviews the process by which the U.S. military acquires vaccines to protect its warfighters from natural infectious disease threats. The committee found that poorly aligned acquisition processes and an inadequate commitment of financial resources within the Department of Defense vaccine acquisition process " rather than uncleared scientific or technological hurdles " contribute to the unavailability of some vaccines that could protect military personnel and, implicitly, the welfare and security of the nation. Protecting Our Forces outlines ways in which DoD might strengthen its acquisition process and improve vaccine availability. Recommendations, which include combining all DoD vaccine acquisition responsibilities under a single DoD authority, cover four broad aspects of the acquisition process: (1) organization, authority, and responsibility; (2) program and budget; (3)manufacturing; (4) and the regulatory status of special-use vaccines. 606 $aVaccines$zUnited States 606 $aVaccines industry$zUnited States 607 $aUnited States$xArmed Forces$xMedical care 615 0$aVaccines 615 0$aVaccines industry 676 $a355.3450973 701 $aLemon$b Stanley M$0885907 712 02$aInstitute of Medicine (U.S.).$bCommittee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910957300903321 996 $aProtecting our forces$94354591 997 $aUNINA